Patents Assigned to Gatekeeper Pharmaceuticals, Inc. - Justia Patents Search

Patents Assigned to Gatekeeper Pharmaceuticals, Inc.

Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith

Patent number: 9879028

Abstract: Provided are compounds and methods for treating or preventing kinase-mediated disorders therewith.

Type: Grant

Filed: September 11, 2013

Date of Patent: January 30, 2018

Assignee: GATEKEEPER PHARMACEUTICALS, INC.

Inventors: Nathanael S. Gray, Wenjun Zhou
Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith

Publication number: 20140011810

Abstract: Provided are compounds and methods for treating or preventing kinase-mediated disorders therewith.

Type: Application

Filed: September 11, 2013

Publication date: January 9, 2014

Applicant: Gatekeeper Pharmaceuticals, Inc.

Inventors: Nathanael S. Gray, Wenjun Zhou